Effects of the new arginase inhibitor N(ω)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages

Nitric Oxide - Biology and Chemistry

Volumn 3, Issue 6, 1999, Pages 427-438

  Tenu, Jean Pierre ^a   Lepoivre, Michel ^a   Moali, Catherine ^b   Brollo, Maurice ^b   Mansuy, Daniel ^b   Boucher, Jean Luc ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

Author keywords

Arginase; Competitive pathways; L arginine metabolism; N( )hydroxy L arginine; Nitric oxide synthase

Indexed keywords

ARGINASE; ARGININE; ENZYME INHIBITOR; N(G) HYDROXYARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALIA; MURINAE;

EID: 0033395710     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1999.0255     Document Type: Article

References (49)

1. Wu G., Morris S. M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1998;1-17.
2. Cynober L., LeBoucher J., Vasson M. P. Arginine metabolism in mammals. J. Nutr. Biochem. 6:1995;402-413.
3. Granger D. L., Hibbs J. B., Perfect J. R., Durack D. T. Metabolic fate of l-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85:1990;264-273.
4. Cook H. T., Jansen A., Lewis S., Largen P., O'Donnell M., Reaveley D., Cattell V. Arginine metabolism in experimental glomerulonephritis: Interaction between nitric oxide synthase and arginase. Am. J. Physiol. 267:1994;F646-F653.
5. Wang W. W., Jenkinson C. P., Griscavage J. M., Kern R. M., Arabolos N. S., Byrns R. E., Cederbaum S. D., Ignarro L. J. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210:1995;1009-1016.
6. Sonoki T., Nagasaki A., Gotoh T., Takiguchi M., Takeya M., Matsuzaki H., Mori M. Coinduction of nitric oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J. Biol. Chem. 272:1997;3689-3693.
7. Jenkinson C. P., Grody W. W., Cederbaum S. D. Comparative properties of arginases. Comp. Biochem. Physiol. Biochem. Mol. Biol. 114B:1997;107-132.
8. Kerwin J. F., Lancaster J. R., Feldman P. L. Nitric oxide: A new paradigm for second messengers. J. Med. Chem. 38:1995;4343-4362.
9. Perozich J., Hempel J., Morris S. M. Roles of conserved residues in the arginase family. Biochim. Biophys. Acta. 1382:1998;23-37.
10. Gotoh T., Sonoki T., Nagasaki A., Terada K., Takiguchi M., Mori M. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett. 395:1996;119-122.
11. Vockley J. G., Jenkinson C. P., Shukla H., Kern R. M., Grody W. W., Cederbaum S. D. Cloning and characterization of the human type II arginase gene. Genomics. 38:1996;118-123.
12. Spector E. B., Jenkinson C. P., Grigor M. R., Kern R. M., Cederbaum S. D. Subcellular localization and differential antibody specificity of arginase in tissue culture and whole animal. Int. J. Dev. Neurosci. 12:1994;337-342.
13. Jenkinson C. P., Grigor M. R. Rat mammary arginase: Isolation and characterization. Biochem. Med. Metab. Biol. 51:1994;156-165.
14. (II) centers in rat liver arginase. J. Am. Chem. Soc. 114:1992;10992-10994.
15. Kanyo Z. F., Scolnick L. R., Ash D. E., Christianson D. W. Structure of a unique binuclear manganese cluster in arginase. Nature. 383:1996;554-557.
16. Modolell M., Corraliza I. M., Link F., Soler G., Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25:1995;1101-1104.
17. 2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206:1995;667-673.
18. Louis C. A., Reichner J. S., Henry W. L., Mastrofrancesco B., Gotoh Y., Mori M., Albina J. E. Distinct arginase isoforms expressed in primary and transformed macrophages: Regulation by oxygen tension. Am. J. Physiol. 274:1998;R775-R782.
19. Waddington S. N., Tam F. W. K., Cook H. T., Cattell V. Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells. Am. J. Physiol. 274:1998;F473-F480.
20. Mori M., Gotoh T., Nagasaki A., Takiguchi M., Sonoki T. Regulation of the urea cycle enzyme genes in nitric oxide synthesis. J. Inher. Metab. Dis. 21:1998;59-71.
21. ω-hydroxy-d,l-indospicine: Effects on l-arginine utilization by nitric oxide synthase. Br. J. Pharmacol. 121:1997;395-400.
22. Chang C. I., Liao J. C., Kuo L. Arginase modulates nitric oxide production in activated macrophages. Am. J. Physiol. 274:1998;H342-H348.
23. Moncada S., Higgs E. A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1995;1319-1330.
24. Knowles R. G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
25. Förstermann U., Closs E. I., Pollock J. S., Nakane M., Schwarz P., Gath I., Kleinert H. Nitric oxide synthase isozymes: Characterization, purification, molecular cloning, and functions. Hypertension. 23:1994;1121-1131.
26. Hrabak A., Idei M., Temesi A. Arginine supply for nitric oxide synthesis and arginase is mainly exogenous in elicited murine and rat macrophages. Life Sci. 55:1994;797-805.
27. Hey C., Wessler I., Racké K. Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;651-659.
28. G-hydroxy-l-arginine: Implication for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun. 202:1994;174-180.
29. ω-Hydroxy-l-arginine, an intermediate in the l-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun. 203:1994;1614-1621.
30. G-hydroxy-l-arginine in alveolar macrophages: Implication for the utilisation of l-arginine for nitric oxide synthesis. FEBS Lett. 359:1995;251-254.
31. G-hydroxy-l-arginine during high-output NO production. Am. J. Physiol. 271:1996;H1988-H1998.
32. ω-Hydroxy-l-arginine, a reactionnal intermediate in nitric oxide biosynthesis, induces cytostasis in human and murine tumor cells. Biochem. Biophys. Res. Commun. 196:1993;1558-1565.
33. G-Hydroxy-l-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol. 275:1998;R1256-R1264.
34. ω-hydroxy-l-arginine by hemeproteins. Biochem. Biophys. Res. Commun. 184:1992;1158-1164.
35. G-hydroxy-l-arginine to nitric oxide mediated by respiratory burst: An alternative pathway to NO synthesis. FEBS Lett. 401:1997;123-126.
36. Kakuda D. K., Finley K. D., Maruyama M., MacLeod C. L. Stress differentially induces cationic amino acid transporter gene expression. Biochem. Biophys. Acta. 1414:1998;75-84.
37. ω-Hydroxy-l-arginine is an intermediate in the biosynthesis of nitric oxide from l-arginine. J. Biol. Chem. 266:1991;6259-6263.
38. ω-hydroxy-l-arginine as an intermediate. J. Biol. Chem. 268:1993;14781-14787.
39. ω-hydroxy-nor-l-arginine. Biochemistry. 37:1998;10453-10460.
40. Reczkowski R. S., Ash D. E. Rat liver arginase: Kinetic mechanism, alternate substrates, and inhibitors. Arch. Biochem. Biophys. 312:1994;31-37.
41. ω-Hydroxyamino-α-amino acids as a new class of very strong inhibitors of arginases. J. BioInorg. Chem. 1:1996;73-82.
42. ω-hydroxy-nor-l-arginine: A high-affinity inhibitor of arginase well adapted to bind to its manganese cluster. J. Am. Chem. Soc. 119:1997;4086-4087.
43. ω-hydroxy arginine: A possible intermediate in the biosynthesis of nitric oxide from arginine. J. Med. Chem. 34:1991;1746-1748.
44. Chenais B., Yapo A., Lepoivre M., Tenu J. P. High-performance liquid chromatographic analysis of the unusual pathway of oxidation of l-arginine to citrulline and nitric oxide in mammalian cells. J. Chromatogr. 539:1991;433-441.
45. 15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
46. Chenais B. Métabolisme de la l-arginine et régulation de l'induction de la NO synthase: Rôle dans les phénomènes antiprolifératifs. 1994;University Paris-Sud, Orsay. p. 50-55.
47. Lepoivre M., Flaman J. M., Bobé P., Lemaire G., Henry Y. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide: Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J. Biol. Chem. 269:1994;21891-21897.
48. Mills C. D., Shearer J., Evans R., Caldwell M. D. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol. 149:1992;2709-2714.
49. Norris K. A., Schrimpf J. E., Flynn J. L., Morris S. M. Enhancement of macrophage microbicidal activity: Supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi. Infect. Immun. 63:1995;2793-2796.